Sun Pharma Plunges 3% On Weak Q2 Nos; Morgan Stanley Underweight

Share price of Sun Pharmaceutical Industries slipped 3 percent in the early trade on Wednesday on the back of poor Q2 numbers.

The company has reported 59 percent decline in net profit to Rs 912.1 crore in the second quarter ended September as the company faces pricing pressure in US generics market.

The company had reported net profit of Rs 2235 crore in the same period of previous year.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory